266
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Protective effect of taraxasterol against LPS-induced endotoxic shock by modulating inflammatory responses in mice

, , &
Pages 11-16 | Received 30 Aug 2013, Accepted 29 Oct 2013, Published online: 29 Nov 2013

References

  • Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471–1477
  • Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885–891
  • Saluk-Juszczak J, Wachowicz B. The proinflammatory activity of lipopolysaccharide. Postepy Biochem 2005;51:280–287
  • Fujihara M, Muroi M, Tanamoto K, et al. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. The proinflammatory activity of lipopolysaccharide. Pharmacol Ther 2003;100:171–194
  • Li P, Sun M, Wohland T, et al. The molecular mechanism of interaction between sushi peptide and Pseudomonas endotoxin. Cell Mol Immunol 2006;3:21–28
  • Shimazu R, Akashi S, Ogata H, et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999;189:1777–1782
  • Zhang XM, Song Y, Ci XX, et al. Effects of florfenicol on early cytokine responses and survival in murine endotoxemia. Int Immunopharmacol 2008;8:982–988
  • Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis 2009;9:281–290
  • Alberti C, Brun-Buisson C, Goodman SV, et al. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med 2003;168:77–84
  • Zheng YJ, Guo ZY, He WG, et al. Ephedrine hydrochloride protects mice from LPS challenge by promoting IL-10 secretion and inhibiting proinflammatory cytokines. Int Immunopharmacol 2012;13:46–53
  • Kisiel W, Barszcz B. Further sesquiterpenoids and phenolics from Taraxacum officinale. Fitoterapia 2000;71:269–273
  • Ahmad VU, Yasmeen S, Ali Z, et al. Taraxacin, a new guaianolide from Taraxacum wallichii. J Nat Prod 2000;63:1010–1011
  • Leu YL, Wang YL, Huang SC, Shi LS. Chemical constituents from roots of Taraxacum formosanum. Chem Pharm Bull 2005;53:853–855
  • Sweeney B, Vora M, Ulbricht C, Basch E. Evidence-based systematic review of dandelion (Taraxacum officinale) by natural standard research collaboration. J Herb Pharmacother 2005;5:79–93
  • Schütz K, Carle R, Schieber A. Taraxacum -- a review on its phytochemical and pharmacological profile. J Ethnopharmacol 2006;107:313–323
  • Jeon HJ, Kang HJ, Jung HJ, et al. Anti-inflammatory activity of Taraxacum officinale. J Ethnopharmacol 2008;115:82–88
  • Park CM, Park JY, Noh KH, et al. Taraxacum officinale Weber extracts inhibit LPS-induced oxidative stress and nitric oxide production via the NF-κB modulation in RAW 264.7 cells. J Ethnopharmacol 2011;133:834–842
  • Koh YJ, Cha DS, Ko JS, et al. Anti-inflammatory effect of Taraxacum officinale leaves on lipopolysaccharide-induced inflammatory responses in RAW 264.7 cells. J Med Food 2010;13:870–878
  • Seo SW, Koo HN, An HJ, et al. Taraxacum officinale protects against cholecystokinin-induced acute pancreatitis in rats. World J Gastroenterol 2005;11:597–599
  • Liu LB, Xiong HZ, Ping JQ, et al. Taraxacum officinale protects against lipopolysaccharide-induced acute lung injury in mice. J Ethnopharmacol 2010;130:389–394
  • Zhang XM, Xiong HZ, Li LB. Effects of taraxasterol on inflammatory responses in lipopolysaccharide-induced RAW 264.7 macrophages. J Ethnopharmacol 2012;14:206–211
  • Liu JT, Xiong HZ, Cheng Y, et al. Effects of taraxasterol on ovalbumin-induced allergic asthma in mice. J Ethnopharmacol 2013;148:787–793
  • Zhang XM, Song Y, Ci XX, et al. Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice. Inflamm Res 2008;57:524–529
  • Muchamuel T, Menon S, Pisacane P, et al. IL-13 protects mice from lipopolysaccharide-induced lethal endotoxemia: correlation with down-modulation of TNF-alpha, IFN-gamma, and IL-12 production. J Immunol 1997;158:2898–2903
  • Beutler B, Rietschel ET. Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 2003;3:169–176
  • Blackwell TS, Christman JW. Sepsis and cytokines: current status. Brit J Anesth 1996;77:110–117
  • LaRosa SP, Opal SM. Sepsis strategies in development. Clin Chest Med 2008;29:735–747
  • Szliszka E, Skaba D, Czuba ZP, Krol W. Inhibition of inflammatory mediators by neobavaisoflavone in activated RAW264.7 macrophages. Molecules 2011;16:3701–3712
  • Mannel DN, Echtenacher B. TNF in the inflammatory response. Chem Immunol 2000;74:141–161
  • Glauser MP. The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock. Drugs 1996;52:9–17
  • Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229:869–871
  • Hu XD, Yang Y, Zhong XG, et al. Anti-inflammatory effects of Z23 on LPS-induced inflammatory responses in RAW264.7 macrophages. J Ethnopharmacol 2008;120:447–451
  • Alexander HR, Doherty GM, Block MI, et al. Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats. Infect Immun 1991;59:3889–3894
  • Sireci G, La Manna MP, Di Sano C, et al. Pivotal advance: alpha-galactosylceramide induces protection against lipopolysaccharide-induced shock. J Leukocyte Biol 2007;81:607–622
  • Molloy RG, Mannick JA, Rodrick ML. Cytokines, sepsis and immunomodulation. Br J Surg 1993;80:289–297
  • West MA, Seatter SC, Bellingham J, Clarir L. Mechanisms of reprogrammed macrophage endotoxin signal transduction after lipopolysaccharide pretreatment. Surgery 1995;118:220–228
  • Van Snick J. IL-6: an overview. Annu Rev Immunol 1990;8:253–278
  • Sharma JN, Al-Omran A, Parvathy SS. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 2007;15:252–259
  • Noguchi K, Ishikawa I. The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontology 2007;43:85–101
  • Zhang XM, Xiong HZ, Li HY, et al. Effects of florfenicol on LPS-induced nitric oxide and prostaglandin E2 production in RAW 264.7 macrophages. Fund Clin Pharmacol 2011;25:591–598
  • Raetz CR. Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction. J Bacteriol 1993;175:5745–5753
  • Kim ND, Kim EM, Kang KW, et al. Ginsenoside Rg3 inhibits phenylephrine-induced vascular contraction through induction of nitric oxide synthase. Brit J Pharmacol 2003;140:661–670
  • Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998;38:97–120
  • Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J 2001;15:2057–2072

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.